News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

AI-Powered Tech Supercharges Ocean Cleanup, Boosting Plastic Collection by 60%
News Release

BALTIMORE, MD, April 23, 2025 – As plastic pollution in the world’s oceans reaches critical levels, groundbreaking new research reveals how artificial intelligence-driven algorithms can dramatically accelerate plastic waste removal – boosting efficiency by more than 60%.

Read More
China’s rare earth minerals power the modern world. Banning their export could destroy it
Media Coverage

Beijing has a virtual monopoly on rare earth minerals—the materials that power everything from military planes to your electric toothbrush.

Read More
Trump’s tech tariff confusion
Media Coverage
The Trump administration’s back-and-forth moves on tariffs for technology products are stirring confusion in a sector heavily reliant on global supply chains.  
Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
New Year Starts with Challenges of COVID-19 Vaccine Rollout

New Year Starts with Challenges of COVID-19 Vaccine Rollout

Relias Media, January 1, 2021

Like certain celebrities, the “vaccine” does not need a first name or modifier. Data from both Pfizer and Moderna have shown their COVID-19 vaccines to be nearly 95% effective in preventing disease in people who received two doses, thus earning a green light from the Food and Drug Administration. Other vaccines in clinical trials also are showing promising results. Although vaccine doses have been distributed to all states, limited quantities will force states to prioritize those who should get the first doses.

As COVID-19 Vaccine Rolls Out, Leaders Need to Roll Up Sleeves

As COVID-19 Vaccine Rolls Out, Leaders Need to Roll Up Sleeves

Relias Media, January 1, 2021

The good news toward the end of 2020 was the emergency approval of two COVID-19 vaccines. Like certain celebrities, the “vaccine” did not need a first name or modifier. Everyone heard of the promising data coming out of Pfizer and Moderna, showing the vaccines to be about 95% effective against preventing COVID-19 in people who received two doses. Other vaccines also showed promising results, and the Food and Drug Administration has already given emergency use authorization (EUA) to the Pfizer and Moderna vaccines.

Help Case Managers Overcome Vaccine Hesitancy

Help Case Managers Overcome Vaccine Hesitancy

Relias Media, January 1, 2021

Many Americans and healthcare workers have doubts and skepticism about the first vaccines for COVID-19, despite the need for a rapid end to the pandemic surge that began to overflow hospitals before the December holidays. “The truth is that healthcare workers are not immune from vaccine hesitancy,” says Tinglong Dai, PhD, associate professor of operations management and business analytics at Johns Hopkins University Carey Business School in Baltimore. “It’s a phenomenon with real public health impacts.”

Why is Maryland's COVID-19 Vaccination Rollout So Slow? Some Cite Lack of Central Planning.

Why is Maryland's COVID-19 Vaccination Rollout So Slow? Some Cite Lack of Central Planning.

The Baltimore Sun, January 8, 2021

It was early Dec. 23 when 100 doses of the Moderna COVID-19 vaccine arrived in Baltimore County, and by evening half had been given to health department workers and half to first responders. About 3,400 more Moderna doses arrived a week later, and 6,825 Pfizer doses arrived after that. They have not all been used, though appointments are scheduled to use many of them. “People have to understand, I can’t now just open a clinic and hope I get vaccine,” said Dr. Gregory Branch, the county health officer. “I have to plan once I know how much vaccine I’m getting.”

Making Sense of the Lagging U.S. COVID-19 Vaccination Effort

Making Sense of the Lagging U.S. COVID-19 Vaccination Effort

Hub, January 8, 2021

It's been three weeks since the COVID-19 vaccines began arriving at hospitals, clinics, and pharmacies. Operation Warp Speed—the U.S. vaccination development, testing, and distribution effort—had made 20 million vaccine doses available by the end of 2020. Yet the U.S. is only approaching 5.5 million vaccines administered so far. Public health experts, policymakers, and the leaders of Operation Warp Speed agree: The U.S. must pick up the pace of vaccination.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine